sciatica pinchednerves

Stem Cell Therapy for Sciatic Injury, Pinched Nerves & Sciatica

Sciatic nerve injury, Lumbar Radiculitis, and Sciatica pain usually result from sports injuries or other activities that compress the sciatic nerve. The pain can be severe in the shoulders, hands/wrists, and may radiate from the lower spine to the buttocks and down the backs of the legs to the calves. In most cases, pain and discomfort are transient and resolve within a few months, whereas some injuries persist. They may require surgery or alternative treatment options such as stem cell therapy.[1]

Stem Cell Therapy for Sciatica Nerve Injury

Sciatic pain is caused by many types of conditions, including:

Using Stem Cells for Sciatic Nerve Injury

Sciatic nerve damage is not permanent and can be reversed effectively at The Regeneration Center. The effects of peripheral neuropathy, Pinched nerves & sciatica can be damaging if left untreated. Conditions that can lead to this injury mainly involve the spine, which is primarily responsible for your movement and function. Others first show symptoms after a serious shoulder injury or damage to the hip joints, knee arthritis, and knee injuries. Imagine having to live a life with sciatic nerve injury and predisposing yourself to several distressing symptoms such as severe pain and muscle weakness, loss of mobility and sensation, and even loss of bowel or bladder control. Your quality of life would be significantly affected if sciatica is not adequately addressed and treated effectively with UC-MSC+ allogenic stem cells.

For this reason, treatment should be applied at the onset of symptoms. Sciatica, or sciatic nerve impingement, can lead to permanent nerve damage from severe injuries or a prolonged, untreated condition.

Long-Term Results of UC-MSC+ Cell Therapy for Nerve Damage

The Role of Adult Stem Cells

Stem cells are the master cells of the human body that can assume the role of any cell. The stem cell therapy process requires adult stem cells, which differ significantly from embryonic cells. Using adult stem cells eliminates the arguments surrounding embryonic stem cell research. The adult cells used to treat chronic pain are called mesenchymal cells. These, in turn, can embrace the cell characteristic and assume the part, be it cartilage, bone, fat “adipose” cells, or nerve cells.

treat-sciatic-nerve-Injury-thailand

These mesenchymal cells may be harvested from the patient’s fat deposits or adipose tissue around the abdomen, or from the patient’s bone marrow (usually from the hip). The harvested cells are then introduced into the injury site to grow and eventually rejuvenate the injured area. If the patient is in poor health and is not a candidate for autologous cell therapy, we can offer immune-compatible cells from cord tissue or placenta-derived cells.

treat-sciatic-nerves-Sciatica

Stem cell therapy is still considered the “last line of defense” to counter permanent nerve injury, as well as the resulting pain and disability for patients with lupus. This innovative regenerative medical treatment aims to bring light to the situation of patients with lingering chronic conditions or those who underwent conservative modalities such as physical therapy or spinal decompression, but without any favorable results.[2]

TREATMENT RISKS & PRECAUTIONS

Please note that not all patients are suitable candidates for treating sciatic injuries, pinched nerves, or sciatica with stem cells. Patients with severe nerve compression, advanced disc degeneration, significant spinal issues, or other major health conditions might not be good candidates for treatment.

Non-Surgical Sciatic Nerve Treatment

If you want to relieve Sciatica without the risks of back surgery or steroid injections, a combination of expanded MSC+ stem cells may be a viable alternative. Our research experience has shown that most people with sciatica prefer not to have surgery or risk the long-term side effects experienced with frequent steroid injections. The regeneration center offers an innovative, highly effective alternative that treats the underlying condition causing the pain. Our new UC-MSC+ sciatica protocol uses an optimal mix of laboratory-expanded UC-MSC+ Cells, neural progenitor cells, and nerve and tissue growth factors for effective results in a multi-stage treatment plan that will require 10-14 days in Bangkok.

The specifics of your SCIATICA protocol will depend entirely on the severity of the underlying condition and other relevant medical factors, such as your health and age. Contact us to determine whether stem cell therapy is appropriate for you, or to learn more about foods that may help with arthritis or how stem cells have helped people with sciatica.[3]

Regeneration-Center-Stem-Cell-Culturing

Cost of Treating Sciatic Nerve Injury with UC-MSC+ Cells

The costs of treating sciatic nerve injuries depend on the extent of spinal or nerve damage. To begin the treatment evaluation, our orthopedic stem cell team will need to conduct a virtual consultation using your recent lab results (MRI, CT Scans) or a medical report from your primary care physician or orthopedic/spinal doctors in your home country. Upon completion of the therapy evaluation, a detailed treatment plan will be provided that includes the exact number of nights required and the total medical costs. To begin the qualification process for our multi-stage relief treatment for pinched nerves & Sciatica, please prepare your recent medical records contact us today.

Published Clinical Citations

[1] ^ Elfar JC, Jacobson JA, Puzas JE, Erythropoietin accelerates functional recovery after peripheral nerve injury. J Bone Joint Surg Am 2008;90:1644-53

[2] ^ The mesenchymal stem cell-derived microvesicles enhance sciatic nerve regeneration: a novel approach in peripheral nerve cell therapy.Raisi A, Azizi S, Delirezh N, Heshmatian B, Farshid AA, Amini K. J Trauma Acute Care Surg. 2014 Apr;76(4):991-7. doi: 10.1097/TA.0000000000000186.

[3] ^ Role of Central Plasticity in the Outcome of Peripheral Nerve Regeneration. Mohanty CB, Bhat D, Devi BI. Neurosurgery. 2015 Sep;77(3):418-23. doi: 10.1227/NEU.0000000000000851.

Page last updated: 09 April 2026 | Topic last reviewed: 12 August 2025